Chemical Structure (Hetlioz 01)
Hetlioz Suspension
Product Images NDC 43068-304
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Hetlioz (NDC 43068-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vanda Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Hetlioz 02)
This appears to be a list of different components for a dosing syringe device, including a bottle cap, barrel, plunger, press-in mechanism, and an adapter for fitting the syringe onto a bottle. A diagram is also mentioned as "Figure A".*
Figure B (Hetlioz 03)
Figure C (Hetlioz 04)
Figure D (Hetlioz 05)
Figure E (Hetlioz 06)
Figure F (Hetlioz 07)
Figure G (Hetlioz 08)
Figure H (Hetlioz 09)
Figure I (Hetlioz 10)
Figure J (Hetlioz 11)
20 mg Bottle (composite) (Hetlioz 12)
The text is a set of instructions for taking a medication called Hetlioz® with a usual dosage of 20 mg. The medication should be taken before bedtime without food. It provides information about storage temperatures and precautions to keep it out of reach of children. It also includes details such as the NDC number and expiration date, and instructions to not cover the Braille on the packaging.*
48 mL Bottle Label (Hetlioz 13)
This is a medication with an NDC code of 43068-304-02. It should be stored in a refrigerator at 5°C (41°F), with permitted excursions to 2°C-8°C (36°F to 46°F). The medication comes with an oral dosing syringe and a press-in bottle adapter. It is recommended to see the package insert for full prescribing information. The medication should be shaken well before use, and the press-in-bottle adapter should be inserted firmly into the bottle's neck. The cap should be replaced after each use, and discard the unused portion 5 weeks after first opening.*
48 mL Carton Label (Hetlioz 14)
This is a description of a medication, NDC 43068-304-02, which includes a 48mL bottle of oral suspension along with an oral dosing syringe and press-in bottle adapter. The product should be stored in a refrigerator at a temperature of 5°C (41°F), with excursions to 1 to 2°C to 8°C permitted. The PIBA should be inserted firmly into the bottle's neck before use. The medication should only be measured with the syringe provided, and the recommended dosage should be inserted into the PIBA and the 4mg/ml suspension should be consumed orally. The medicine must be used within two weeks of its first opening and kept away from children. The package insert should be consulted for full prescribing instructions.*
158 mL Bottle Label (Hetlioz 15)
This appears to be the labeling information for a prescription medication called Hetli-loz LQ, containing tasimelteon in an oral suspension form. The label includes information on recommended dosage, storage instructions, and precautions for use, including the use of an oral dosing syringe and press-in bottle adapter provided with the product. The medication should be stored in a refrigerator and used within 8 weeks of opening, with any unused portion discarded after that time. The label is distributed by Vanda Pharmaceuticals and includes a lot number and expiration date field.*
158 mL Carton Label (Hetlioz 16)
This is a medication that comes in a 158 mL bottle with an oral dosing syringe and a press-in-bottle adapter. The medication should be stored in a refrigerator at 5°C and used within 8 weeks of opening it for the first time. There are recommended dosages that can be found inside the packaging. The product should be kept out of the reach of children. The preparation instructions indicate that the press-in-bottle adapter should be inserted into the neck of the bottle before use and the dosing syringe should be inserted into the adapter for withdrawal of the dose. The medication should be shaken well before use and should only be dispensed in the original container.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
